The Use of Heparin as Bridging Therapy When Long-Term Oral Anticoagulants are Interrupted for an Elective Procedure or Surgery

Bridging update edited by Dr Alex Spyropoulos and Dr Marc Cohen covering the use of heparin as bridging therapy when long-term oral anticoagulants are interrupted for an elective procedure or surgery, generated from a monograph on antithrombotic therapy in cardiovascular patients.

This activity has been developed for pharmacists and/or clinical pharmacists, and other health care professionals who treat the 3 main groups of patients affected by bridging therapy: patients with atrial fibrillation, patients with mechanical heart valves, and patients with previous venous thromboembolism.

This program is supported by an educational grant from sanofi-aventis U.S.